Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMARCA5 antisense RNA 1 (SMARCA5-AS1) is a long non-coding RNA gene in the human genome, located on chromosome 4, transcribed antisense to the SMARCA5 protein-coding gene[1][5]. There is currently no detailed functional or clinical annotation for SMARCA5-AS1 as a molecular target in the literature. Unlike its overlapping protein-coding counterpart SMARCA5—which is involved in chromatin remodeling, DNA repair, and transcription—SMARCA5-AS1 is not understood to play a direct role in canonical biological processes, disease states, or therapeutic targeting based on present data[1][5]. It may contribute, as with other antisense RNAs, to the regulation of the corresponding sense gene, but concrete findings or clinical relevance are missing in these search results. SMARCA5-AS1 is different from SMARCA5, which is a protein-coding gene with enzyme and chromatin-remodeling functions (often discussed as SNF2H or an ATPase/helicase component of the ISWI family)[2][3][6]. If you intended to search for the protein-coding gene *SMARCA5*, all target categories and therapeutic information would shift significantly, as SMARCA5 is a well-studied protein involved in chromatin dynamics, cell cycle, DNA replication, repair, and cancer[2][3][4][6]. For structured data purposes, SMARCA5-AS1 is best classified as: - Long non-coding RNA, not enzyme or receptor - Not a drug target - No known drugs or mechanisms of action If you seek information about the protein-coding gene SMARCA5/SNF2H, please clarify or submit a new query.
None cited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SMARCA5 antisense RNA 1 (SMARCA5-AS1).